Researchers Develop A Better Botox

April 12, 2006
A research team at the Scripps Research Institute in La Jolla California has found a way to intensify the effects of the popular Botox treatment, which is commonly used for diminishing the signs of aging and wrinkles.

Dr. Kim Janda, the pioneer of the study, claims that research has found a way to develop a synthetic molecule which “superactivates” the neurotoxin responsible for Botox's paralyzing effects.

The new botulinum neurotoxin (Botox) is estimated to be as much as 14 times as effective as traditional Botox treatments and requires a significantly lower dose . The lower more powerful dose of the toxin has also shown to reduce the risk of immune system complications and have longer lasting effects than the original treatment.

“We have developed a synthetic molecule that binds to the toxin and increases its normal function,” said Janda. “The discovery of small molecule activators may ultimately provide a valuable method for minimizing dosage, reducing resistance, and increasing its clinical efficacy.”

Though it is a poisonous toxin, botulinum neurotoxin has shown to have significant medical benefits for people with migraines, excessive sweating and lazy eyes. The discovery of Botox's clinical benefits for curing wrinkles was discovered through treatment of these conditions.

Today, Botox is one of the most commonly sought non-surgical cosmetic procedures in the United States.

To learn more about Botox and other non-surgical cosmetic procedures, you may wish to confer with a board certified plastic surgeon.

More News...